265648-47-3

Basic information

• Product Name: N-[3-benzoyl-4-(3,5,5-trimethylhexanoylamino)phenyl]-N^α-tert-butyloxycarbonyl-S-tritylcysteinamide
• Synonyms: N-[3-benzoyl-4-(3,5,5-trimethylhexanoylamino)phenyl]-N^α-tert-butyloxycarbonyl-S-tritylcysteinamide
• CAS NO: 265648-47-3
• Molecular Weight: 798.059
• Mol File: 265648-47-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[3-benzoyl-4-(3,5,5-trimethylhexanoylamino)phenyl]-N^α-tert-butyloxycarbonyl-S-tritylcysteinamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-benzoyl-4-(3,5,5-trimethylhexanoylamino)phenyl]-N^α-tert-butyloxycarbonyl-S-tritylcysteinamide(265648-47-3)
• EPA Substance Registry System: N-[3-benzoyl-4-(3,5,5-trimethylhexanoylamino)phenyl]-N^α-tert-butyloxycarbonyl-S-tritylcysteinamide(265648-47-3)

Safety Data

• Hazardous Substances Data: 265648-47-3(Hazardous Substances Data)

Upstream product

• 265648-45-1 N-(2-benzoyl-4-nitrophenyl)-3,5,5-trimethylhexanoylamide 
• 36727-29-4 isononanoyl chloride 
• 21947-98-8 N-tert-butyloxycarbonyl-S-trityl-L-cysteine 
• 265648-46-2 N-(4-amino-2-benzoylphenyl)-3,5,5-trimethylhexanoylamide 
• 1775-95-7 2-amino-5-nitrobenzophenone 

Relevant articles and documents

Synthesis, molecular modeling, and structure - Activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors

Because of the involvement of farnesylated proteins in oncogenesis, inhibition of the protein-modifying enzyme farnesyltransferase is considered a major emerging strategy in cancer therapy. Here, we describe the structure - activity relationship of a nove